22 COVID-19 vaccines enter clinical trials in China: health official
Share - WeChat

BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- Pet owners embrace traditional Chinese veterinary treatments for their beloved pets
- China to recruit over 20,000 special post teachers for rural areas
- Scientists develop contact lenses that let humans see near-infrared light
- China leading globally in installed hydropower capacity
- Humanoid robot introduces China Daily
- 6 million cyberspace IDs granted in China